About: http://data.cimple.eu/news-article/973c84c65ae9a790e43186460100f69dc4ab2eb065938d2a8dca394a

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/973c84c65ae9a790e43186460100f69dc4ab2eb065938d2a8dca394a Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	Even people with minor illness from the coronavirus can develop antibodies that could leave them immunised for several weeks or more, according to an early French study that tested hospital staff with mild infections. Researchers said the results, which have not yet been peer reviewed, were "encouraging" since little is known about the mechanisms of immunity against the novel coronavirus, especially in people with minor forms of the disease. "We knew that people with severe forms of the disease developed antibodies within 15 days of the onset of symptoms," said Arnaud Fontanet, head of the global health department at the Institut Pasteur, which conducted the research with the University Hospital in Strasbourg. "We now know that this is also true for those who develop minor forms, even if the rates of antibodies are probably weaker." The study was carried out on 160 members of staff at two hospital sites in Strasbourg who had all tested positive for COVID-19 and suffered mild forms of the disease. Two types of serological tests, which aim to look for a previous infection, indicated that almost all health workers -- 153 out of 160 in one case, 159 out of 160 in the other -- had developed antibodies within 15 days after the onset of infection. Using a separate test to determine if the antibody could neutralise the virus, the study found some 98 percent of the volunteers had these antibodies between 28 and 41 days after the first signs of infection. The researchers said in a statement on Tuesday that the neutralising activity of the antibodies appeared to increase over time. Olivier Schwartz, head of Pasteur's virus and immunity unit, said the objective would now be to monitor the "persistence of the antibody response and their capacity to neutralise" the virus over the longer term. pr/abd/klm/mh/dl
schema:headline	Even mild coronavirus illness may confer some immunity: study
schema:mentions	Teaching hospital Global health CONFER (software) Strasbourg French language Antibody Immune system Virus Coronavirus Severe acute respiratory syndrome coronavirus 2 Fontanet, Indiana Serology Davy Arnaud Pasteur Institute KLM
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2020-05-26 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	negative sentiment
http://data.cimple...readability_score	90 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 5 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software